Menu Search
Equities

R1 RCM Inc

6HL0:DEU

R1 RCM Inc

Actions
  • Price (EUR)13.50
  • Today's Change0.10 / 0.75%
  • Shares traded0.00
  • 1 Year change+45.95%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

R1 RCM Inc. is a provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups. The Company’s scalable operating models seamlessly complement a healthcare organization’s infrastructure, driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. The Company delivers solutions to customers through technology, intellectual property (IP), global scale, and operational excellence. Its Intelligent Automation modernizes processes, removes friction, and simplifies revenue cycle management (RCM). Its use of artificial intelligence (AI) in its platform depends on the availability and pricing of equipment and technical infrastructure from third parties, including Microsoft Azure. It serves over 3,700 hospitals, including 93 of the top 100 health systems, and over 30,000 physicians.

  • Revenue in USD (TTM)2.46bn
  • Net income in USD-61.20m
  • Incorporated2022
  • Employees29.40k
  • Location
    R1 RCM Inc434 W. Ascension Way, 6Th FloorMURRAY 84123United StatesUSA
  • Phone+1 (312) 324-7820
  • Fax+1 (302) 655-5049
  • Websitehttps://www.r1rcm.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		RCM:NSQ since
announced		Transaction
value
Acclara Solutions LLCDeal completed06 Dec 202306 Dec 2023Deal completed30.12%680.73m
Data delayed at least 15 minutes, as of Nov 13 2024 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.